5 results
SGLT2 Inhibitors 
SGLT2 inhibitors are the newest class of anti-diabetic medications, with the first one (Canagliflozin)
class of anti-diabetic ... medications, with ... kidney), which causes ... SGLT2 #Inhibitors #Pharmacology ... #Diabetes #Endocrinology
Diabetes Mellitus Type 2 Inpatient Medication Guide

Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
Type 2 Inpatient Medication ... Guide Classes ... #pharmacology # ... comparison #table ... #endocrinology
Causes of Hypomagnesemia
Redistribution:
 - IV glucose
 - Correction of diabetic ketoacidosis
 - IV hyperalimentation
 - Refeeding
Causes of Hypomagnesemia ... Correction of diabetic ... #diagnosis #differential ... #medications #drugs ... #pharmacology #
Pharmaceutical agents other than olmesartan have been reported to cause villous atrophy on occasion and are
are listed in Table ... of drug-induced ... #Pharmacology #Drugs ... #Induced #Medications ... #Differential #
Rybelsus (oral semaglutide) - First Oral GLP-1 Agonist
Dosing:
3 mg daily x 30 days, then 7 mg
semaglutide, the same medication ... to remain stable ... #semaglutide #Diabetes ... #Pharmacology # ... Endocrinology